The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis
Open Access
- 30 May 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (11) , 9489
Abstract
Various chronic inflammatory airway diseases can be treated with low-dose, long-term (LDLT) macrolide therapy. LDLT macrolides can be one of the therapeutic options for chronic rhinosinusitis (CRS) due to their immunomodulatory and anti-inflammatory actions. Currently, various immunomodulatory mechanisms of the LDLT macrolide treatment have been reported, as well as their antimicrobial properties. Several mechanisms have already been identified in CRS, including reduced cytokines such as interleukin (IL)-8, IL-6, IL-1β, tumor necrosis factor-α, transforming growth factor-β, inhibition of neutrophil recruitment, decreased mucus secretion, and increased mucociliary transport. Although some evidence of effectiveness for CRS has been published, the efficacy of this therapy has been inconsistent across clinical studies. LDLT macrolides are generally believed to act on the non-type 2 inflammatory endotype of CRS. However, the effectiveness of LDLT macrolide treatment in CRS is still controversial. Here, we reviewed the immunological mechanisms related to CRS in LDLT macrolide therapy and the treatment effects according to the clinical situation of CRS.Keywords
Funding Information
- National Research Foundation of Korea (20016285)
This publication has 112 references indexed in Scilit:
- Azithromycin and the Risk of Cardiovascular DeathNew England Journal of Medicine, 2012
- Effect of long-term, low-dose clarithromycin on T helper 2 cytokines, eosinophilic cationic protein and the ‘regulated on activation, normal T cell expressed and secreted’ chemokine in the nasal secretions of patients with nasal polyposisThe Journal of Laryngology & Otology, 2012
- Azithromycin Inhibits Mucus Hypersecretion from Airway Epithelial CellsMediators of Inflammation, 2012
- Clarithromycin Suppresses Human Respiratory Syncytial Virus Infection-InducedStreptococcus pneumoniaeAdhesion and Cytokine Production in a Pulmonary Epithelial Cell LineMediators of Inflammation, 2012
- Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory MedicationsClinical Microbiology Reviews, 2010
- Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF‐κBRespirology, 2008
- Novel Effects of Azithromycin on Tight Junction Proteins in Human Airway EpitheliaAntimicrobial Agents and Chemotherapy, 2006
- ‘Subinhibitory’ Erythromycin Represses Production of Pseudomonas aeruginosa Lectins, Autoinducer and Virulence FactorsChemotherapy, 1999
- Effect of Roxithromycin on IL-8 Synthesis and Proliferation of Nasal Polyp FibroblastsActa Oto-Laryngologica, 1998
- The use of macrolide antibiotic substances in the treatment of asthmaJournal of Allergy, 1970